Deciphering dual clinical entities associated with TP53 pathogenic variants - Insights from 53,085 HBOC panel analyses in French laboratories
Favorite
Share
More Options
11

Open in WPS to view all 11 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
